Patent · US Active

Crystalline HMO

US10407516B2 · kind B2 · utility

1Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2017
Grant dateSep 10, 2019
Priority date—
Expiry dateNov 4, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA23V2002/00
  • WIPO fieldFood chemistry
  • WIPO sectorChemistry

Abstract

Crystalline pLNnH, useful in a pharmaceutical or nutritional composition, is disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.